Published in Endocrinology on March 01, 1972
Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest (1994) 1.82
Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J Clin Invest (1986) 1.67
Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines. J Clin Invest (1974) 1.61
Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest (1974) 1.55
Glucose modulation of amino acid-induced glucagon and insulin release in the isolated perfused rat pancreas. J Clin Invest (1974) 1.27
A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids. Biochem J (1982) 0.97
Cyclic adenosine monophosphate differently affects the response of mouse pancreatic beta-cells to various amino acids. J Physiol (1986) 0.87
Culture medium for enterobacteria. J Bacteriol (1974) 37.59
Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell (1998) 5.52
Fetal alcohol syndrome in adolescents and adults. JAMA (1991) 4.17
The oxygen supply of the foetal brain of the sheep and the effect of asphyxia on foetal respiratory movement. J Physiol (1940) 3.37
Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med (1997) 3.35
Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology (1968) 3.23
Vitamin D deficiency inhibits pancreatic secretion of insulin. Science (1980) 3.00
Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science (1973) 2.99
Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol (1992) 2.98
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90 chaperone machinery. J Biol Chem (1998) 2.63
Immunological modulation and evasion by helminth parasites in human populations. Nature (1993) 2.62
Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest (1984) 2.52
Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms. Anal Biochem (1980) 2.29
Cation requirements for insulin secretion in the isolated perfused pancreas. Diabetes (1966) 2.21
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest (1972) 2.20
Prevention of osteoporosis in glucocorticoid-treated neurology patients. Clin Neurol Neurosurg (2005) 2.19
Tissue effects of glucocorticoids. Am J Med (1972) 2.11
Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology (2000) 2.08
Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70. Mol Endocrinol (1996) 2.07
A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science (1981) 2.02
The response of human leucocyte cultures to stimulation by tuberculin and phytohaemagglutinin measured by the uptake of radioactive thymidine. Clin Exp Immunol (1967) 2.01
Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia (1984) 1.99
Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care (1995) 1.99
Differential interactions of p23 and the TPR-containing proteins Hop, Cyp40, FKBP52 and FKBP51 with Hsp90 mutants. Cell Stress Chaperones (1998) 1.91
The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun (2000) 1.91
Requirement for calcium ion in insulin secretion by the perfused rat pancreas. Am J Physiol (1968) 1.82
Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med (1975) 1.80
Acylation-dependent protein export in Leishmania. J Biol Chem (2000) 1.77
Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes. Mol Endocrinol (1998) 1.76
Evidence for a mechanism of repression of heat shock factor 1 transcriptional activity by a multichaperone complex. J Biol Chem (2001) 1.75
Patients' experiences of injury as a result of epilepsy. Epilepsia (1997) 1.73
Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J Immunol (2000) 1.72
A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1, and the aryl hydrocarbon receptor. Cell Stress Chaperones (1996) 1.68
Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol Cell Biol (1997) 1.65
Molecular cloning of human p48, a transient component of progesterone receptor complexes and an Hsp70-binding protein. Mol Endocrinol (1996) 1.64
An assessment of error in parental occupation from the birth certificate. Am J Epidemiol (1990) 1.58
Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab (1999) 1.58
Characterisation of bacterial clones containing DNA sequences derived from Xenopus laevis vitellogenin mRNA. Nucleic Acids Res (1979) 1.57
Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen Comp Endocrinol (2001) 1.57
The in vitro perfused pancreas. Methods Enzymol (1975) 1.56
The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry (2004) 1.55
Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest (1974) 1.55
Removal of the cecum, including the ileocecocolic junction, and its effects on digestibility in cattle. Am J Vet Res (1983) 1.54
A test-retest study of intelligence in patients with fetal alcohol syndrome: implications for care. J Am Acad Child Adolesc Psychiatry (1991) 1.54
The selectin GMP-140 binds to sialylated, fucosylated lactosaminoglycans on both myeloid and nonmyeloid cells. J Cell Biol (1991) 1.53
Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences. Arch Biochem Biophys (1987) 1.51
Insulin secretion. Interrelationships of glucose, cyclic adenosine 3:5-monophosphate, and calcium. J Biol Chem (1975) 1.50
Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas. N Engl J Med (1978) 1.48
Effect of selected hexoses, of epinephrine and of glucagon on insulin secretion in man. Diabetes (1966) 1.48
Molecular chaperone interactions with steroid receptors: an update. Mol Endocrinol (2000) 1.47
Postoperative studies of adrenal function in primary aldosteronism. J Clin Endocrinol Metab (1966) 1.45
Adenosine 3',5'-monophosphate in pancreatic islets: glucose-induced insulin release. Science (1973) 1.43
Immunologic studies of adrenocorticotropic hormone (ACTH): dissociation of biologic and immunologic activities. J Clin Endocrinol Metab (1965) 1.38
Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab (1973) 1.34
The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications (2000) 1.33
Binding of heat shock proteins to the avian progesterone receptor. Mol Cell Biol (1989) 1.29
Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes (1980) 1.29
Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values. J Cereb Blood Flow Metab (1998) 1.29
The molecular cloning of a dispersed set of developmentally regulated genes which encode the major larval serum protein of D. melanogaster. Cell (1981) 1.27
Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes (1977) 1.25
Mutational analysis of the hsp70-interacting protein Hip. Mol Cell Biol (1996) 1.24
Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab (1998) 1.23
Regulation of pancreatic insulin and glucagon secretion. Annu Rev Physiol (1976) 1.23
The antidiuretic action of acetaminophen. Am J Med Sci (1966) 1.22
GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida. FEBS Lett (2001) 1.21
Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia (1974) 1.21
Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition. Kidney Int (2001) 1.20
Characterization of the glucagon response to hypoglycemia in man. J Clin Endocrinol Metab (1974) 1.20
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess (2007) 1.18
Plasma testosterone stimulation-suppression dynamics in hirsute women. correlation with long-term therapy. Am J Med (1973) 1.17
Effect of diphenylhydantoin on insulin secretion in man. N Engl J Med (1972) 1.17
Stimulation of insulin release by glucagon in noninsulin-dependent diabetics. Metabolism (1966) 1.17
Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone. N Engl J Med (1965) 1.16
Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. JAMA (1975) 1.16
Detection of glycolipid ligands by direct binding of carbohydrate-binding proteins to thin-layer chromatograms. Methods Enzymol (1982) 1.15
Xenon Difluoride and the Nature of the Xenon-Fluorine Bond. Science (1963) 1.14
Vitellogenesis: a versatile model for hormonal regulation of gene expression. Recent Prog Horm Res (1979) 1.14
A threshold distribution hypothesis for packet storage of insulin. II. Effect of calcium. Diabetes (1972) 1.14
Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. J Clin Invest (1976) 1.13
Growth hormone responses following double pulse oral glucose administration in various clinical states. J Clin Endocrinol Metab (1975) 1.12
Pancreatic action of the sulfonylureas. Fed Proc (1977) 1.11
Right-side torsion of the abomasum in dairy cows: classification of severity and evaluation of outcome. J Am Vet Med Assoc (1978) 1.10
Mutation of Hip's carboxy-terminal region inhibits a transitional stage of progesterone receptor assembly. Mol Cell Biol (1998) 1.10
Phenotypic changes associated with deletion and overexpression of a stage-regulated gene family in Leishmania. Cell Microbiol (2001) 1.10
The relationship of obesity and growth hormone to serum insulin levels. Ann N Y Acad Sci (1965) 1.09
Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. N Engl J Med (1974) 1.08
Expression of hydrophilic surface proteins in infective stages of Leishmania donovani. Mol Biochem Parasitol (1999) 1.08
Insulin and the pancreas. Annu Rev Physiol (1966) 1.08
Development of prognostic index for primary supratentorial intracerebral tumours. J Neurol Neurosurg Psychiatry (1992) 1.08
[Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system]. Acta Diabetol Lat (1969) 1.08
Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia (1980) 1.06